论文部分内容阅读
为进一步了解抗心梗合剂(代号109)的疗效机理,我们心肺血管医疗研究中心冠心病组和广安门医院冠心病组协作,重点观察了抗心梗合剂对急性心肌梗塞病例治疗前后和对照组治疗前后(用极化液等非活血化瘀药)血小板功能的变化。
To further understand the therapeutic mechanism of anti-infarction agent (code 109), our Coronary and Cardiovascular Research Center coronary heart disease group and the Guanganmen Hospital coronary heart disease group collaboration focused on anti-myocardial infarction agent in patients with acute myocardial infarction before and after treatment and control group Before and after treatment (with the polar fluid and other non-blood circulation drugs) changes in platelet function.